EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Concurrent Mold, Mycobacterial, and Viral Infections in a Hematopoietic Stem Cell Transplant Recipient Undergoing Lung Transplantation for Graft-Versus-Host Disease

Layan Akkielah, Wayne Leung, Serena Wang, Lili Ataie iD, Anargyros Xenocostas, Asma Syed, Ying-Han R Hsu iD, Michael Silverman, Fatimah AlMutawa iD, MohammadReza Rahimi Shahmirzadi iD

Current Oncology · 02.03.2026 · 33 (3) · 145

DOI: 10.3390/curroncol33030145 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Current Oncology, online erschienen am 02.03.2026. Verfasst von Layan Akkielah und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Infectious Diseases, Western University, London Health Sciences Centre, London, ON N6A 4V2, Canada. Hauptthemen laut MEDLINE: Antifungal Agents, Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Lung Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hematopoietic stem cell transplant (HSCT) recipients are at high risk for opportunistic infections due to profound immunosuppression and graft-versus-host disease (GvHD). Molds and nontuberculous mycobacteria (NTM) pose diagnostic and therapeutic challenges, especially when infections overlap. A 42-year-old woman with prior allogeneic HSCT for acute myeloid leukemia (AML) developed pulmonary infections with Microascus spp. and Mycobacterium chimaera, later complicated by Aspergillus calidoustus and RSV infection. Initial therapy included voriconazole, amphotericin B, and a macrolide-based multidrug regimen for NTM. Modifications were required for drug resistance and hepatotoxicity. Despite partial response, recurrent fungal infection necessitated prolonged antifungal therapy, including adjunctive inhaled amphotericin B and terbinafine. Ultimately, progressive bronchiolitis obliterans prompted bilateral lung transplantation. Explant pathology revealed necrotizing granulomas positive for NTM and Microascus spp. Post-transplant prophylaxis with voriconazole, rifabutin, azithromycin, and inhaled amikacin prevented recurrence, and the patient remained clinically stable at 6-month follow-up. This case illustrates the complexity of managing overlapping mold and NTM infections in HSCT recipients, highlighting the need for individualized, multidisciplinary care. Therapeutic drug monitoring, careful adjustment for drug–drug interactions, and the use of adjunctive inhaled antifungals were critical to achieving a favorable outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsGraft vs Host DiseaseHematopoietic Stem Cell TransplantationLung TransplantationMycobacterium Infections, NontuberculousLung Diseases, FungalAdultFemaleHumans

Stichwörter der Autor:innen

hematopoietic stem cell transplantationnon-aspergillus mold infectionnontuberculous mycobacteria

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Department of Medicine, Division of Infectious Diseases, Western University, London Health Sciences Centre, London, ON N6A 4V2, Canada.
  • Division of Hematology, Department of Medicine, Western University, London Health Sciences-Victoria Hospital, London, ON N6A 4V2, Canada.
  • Department of Transplant Infectious Diseases, Division of Infectious Diseases, University Health Network, University of Toronto, Toronto, ON M5G 2C4, Canada.
  • Laboratory Medicine Program, University Health Network, Toronto, ON M5G 2C4, Canada.
  • Department of Pathology and Laboratory Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 4V2, Canada.

ORCID-Profile: Lili Ataie, Ying-Han R Hsu, Fatimah AlMutawa, MohammadReza Rahimi Shahmirzadi

Zitieren

APA

Akkielah, L., Leung, W., Wang, S., Ataie, L., Xenocostas, A., Syed, A., Hsu, Y. R., Silverman, M., AlMutawa, F., & Rahimi Shahmirzadi, M. (2026). Concurrent Mold, Mycobacterial, and Viral Infections in a Hematopoietic Stem Cell Transplant Recipient Undergoing Lung Transplantation for Graft-Versus-Host Disease. Current Oncology, 33(3), 145. https://doi.org/10.3390/curroncol33030145

Vancouver

Akkielah L, Leung W, Wang S, Ataie L, Xenocostas A, Syed A, et al. Concurrent Mold, Mycobacterial, and Viral Infections in a Hematopoietic Stem Cell Transplant Recipient Undergoing Lung Transplantation for Graft-Versus-Host Disease. Current Oncology. 2026;33(3):145. doi:10.3390/curroncol33030145

BibTeX
@article{Akkielah2026,
  author = {Akkielah, Layan and Leung, Wayne and Wang, Serena and Ataie, Lili and Xenocostas, Anargyros and Syed, Asma and Hsu, Ying-Han R and Silverman, Michael and AlMutawa, Fatimah and Rahimi Shahmirzadi, MohammadReza},
  title = {Concurrent Mold, Mycobacterial, and Viral Infections in a Hematopoietic Stem Cell Transplant Recipient Undergoing Lung Transplantation for Graft-Versus-Host Disease},
  journal = {Current Oncology},
  year = {2026},
  volume = {33},
  number = {3},
  pages = {145},
  doi = {10.3390/curroncol33030145}
}
Kostenlos starten →